Moreover, it has been shown that starting ART in the initial phase of infection might allow for the preservation of the immune system, and specifically of: (1) the CD4+ T-cell count and CD4/CD8 ratio [13-15]; (2) HIV-specific immune responses, preserving the ability to control viral replication [16]; (3) higher levels of mucosal and systemic Th17 cells; (4) lower levels of B-lymphocyte activation, and (5) reconstitution of the NK phenotype [12, 17, 18]. Here, CD4 is linked to infection.